Novo Nordisk (NVO) stock is soaring Friday after the Danish pharmaceutical company reported positive early stage results for its once-weekly weight loss drug Amycretin.
The topline results from the Phase 1b/2a clinical trial showed that patients treated with Amycretin achieved a body weight loss of 9.7% in 20 weeks on 1.25 milligrams, 16.2% in 28 weeks on 5 milligrams and 22% in 36 weeks on 20 milligrams of the drug. Meanwhile, patients treated with the placebo experienced weight gains of 1.9%, 2.3% and 2%, respectively.
"We are very encouraged by the subcutaneous Phase 1b/2a results for Amycretin in people living with overweight or obesity," said Martin Lange, executive vice president for Development at Novo Nordisk. "The results seen in the trial support the weight lowering potential of this novel unimolecular GLP-1 and amylin receptor agonist, Amycretin, that we have previously seen with the oral formulation."
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Based on the positive results, Novo Nordisk said it is now planning further clinical development of the drug.
Is Novo Nordisk stock a buy, sell or hold?
Novo Nordisk has underperformed the broad market on the price charts over the past 12 months, down 17% vs the S&P 500's 27% gain. But Wall Street remains bullish on the healthcare stock.
According to S&P Global Market Intelligence, the average analyst target price for NVO stock is $113.44, representing implied upside of more than 30% to current levels. Additionally, the consensus recommendation is a Buy.
Financial services firm Argus Research is one of those firms with a Buy rating on NVO stock, along with a $110 price target.
"The company is working with regulators on new indications for its GLP-1 treatments and is also focused on launching new products," wrote Argus Research analyst Jasper Hellweg in a January 16 note. "On the fundamentals, the shares trade at 22 times our 2025 earnings-per-share estimate, well below the stock's five-year historical average of 31. Given the company's strong track record and growth outlook, we believe that a higher multiple is warranted."
Related Content
-
Twilio Stock Soars on Strong Profit Forecasts: What to KnowTwilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an investor event.
-
Verizon Sails to the Top of the Dow After Earnings Beat: What to KnowVerizon stock is one of the best Dow Jones stocks Friday after the telecommunications giant beat estimates for its fourth quarter. Here's what you need to know.
-
Twilio Stock Soars on Strong Profit Forecasts: What to Know
Twilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an investor event.
-
Verizon Sails to the Top of the Dow After Earnings Beat: What to Know
Verizon stock is one of the best Dow Jones stocks Friday after the telecommunications giant beat estimates for its fourth quarter. Here's what you need to know.
-
What American Express' Latest Dividend Hike Means for InvestorsIn addition to an earnings beat, American Express disclosed a 17% increase to its quarterly dividend. Here's what that means for the Dow Jones stock.
-
Secure Your Retirement Paycheck: The Power of Three BucketsPutting all of your nest egg in one basket is risky. Try putting it in three buckets for short-term, medium-term and long-term needs instead.
-
Five Reasons You Might Hate Your Insurance Company (and Why You Shouldn't)Stories about insurance companies letting down their customers are easy to come by, but there's another side to many of those stories.
-
Stock Market Today: Dow Adds 408 Points as Trump Answers Davos QuestionsTech stocks surged late and the S&P 500 established its first new all-time closing high of 2025.
-
EA Stock Crashes on Earnings Warning. Should Investors Be Worried?EA stock is spiraling Thursday after video game maker Electronic Arts released preliminary quarterly numbers and lowered its full-year bookings guidance.
-
Is GE Aerospace Stock Still a Buy After Earnings?GE Aerospace stock is higher Thursday after the industrial firm topped analysts' fourth-quarter expectations and issued a strong full-year outlook. Here's what you need to know.
